321 related articles for article (PubMed ID: 36217821)
1. Cannabinoid signaling modulation through JZL184 restores key phenotypes of a mouse model for Williams-Beuren syndrome.
Navarro-Romero A; Galera-López L; Ortiz-Romero P; Llorente-Ovejero A; de Los Reyes-Ramírez L; Bengoetxea de Tena I; Garcia-Elias A; Mas-Stachurska A; Reixachs-Solé M; Pastor A; de la Torre R; Maldonado R; Benito B; Eyras E; Rodríguez-Puertas R; Campuzano V; Ozaita A
Elife; 2022 Oct; 11():. PubMed ID: 36217821
[TBL] [Abstract][Full Text] [Related]
2. Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment.
Guindon J; Lai Y; Takacs SM; Bradshaw HB; Hohmann AG
Pharmacol Res; 2013 Jan; 67(1):94-109. PubMed ID: 23127915
[TBL] [Abstract][Full Text] [Related]
3. Repeated low-dose administration of the monoacylglycerol lipase inhibitor JZL184 retains cannabinoid receptor type 1-mediated antinociceptive and gastroprotective effects.
Kinsey SG; Wise LE; Ramesh D; Abdullah R; Selley DE; Cravatt BF; Lichtman AH
J Pharmacol Exp Ther; 2013 Jun; 345(3):492-501. PubMed ID: 23412396
[TBL] [Abstract][Full Text] [Related]
4. Monoacylglycerol lipase inhibitor JZL184 improves behavior and neural properties in Ts65Dn mice, a model of down syndrome.
Lysenko LV; Kim J; Henry C; Tyrtyshnaia A; Kohnz RA; Madamba F; Simon GM; Kleschevnikova NE; Nomura DK; Ezekowitz RA; Kleschevnikov AM
PLoS One; 2014; 9(12):e114521. PubMed ID: 25474204
[TBL] [Abstract][Full Text] [Related]
5. Blockade of endocannabinoid hydrolytic enzymes attenuates precipitated opioid withdrawal symptoms in mice.
Ramesh D; Ross GR; Schlosburg JE; Owens RA; Abdullah RA; Kinsey SG; Long JZ; Nomura DK; Sim-Selley LJ; Cravatt BF; Akbarali HI; Lichtman AH
J Pharmacol Exp Ther; 2011 Oct; 339(1):173-85. PubMed ID: 21719468
[TBL] [Abstract][Full Text] [Related]
6. Dysfunctional Mitochondria in the Cardiac Fibers of a Williams-Beuren Syndrome Mouse Model.
Abdalla N; Tobías-Baraja E; Gonzalez A; Garrabou G; Egea G; Campuzano V
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373217
[TBL] [Abstract][Full Text] [Related]
7. Monoacylglycerol Lipase Inhibition Using JZL184 Attenuates Paw Inflammation and Functional Deficits in a Mouse Model of Inflammatory Arthritis.
Nass SR; Steele FF; Ware TB; Libby AH; Hsu KL; Kinsey SG
Cannabis Cannabinoid Res; 2021 Jun; 6(3):233-241. PubMed ID: 34042520
[No Abstract] [Full Text] [Related]
8. Endocannabinoid-mediated modulation of Gq/11 protein-coupled receptor signaling-induced vasoconstriction and hypertension.
Szekeres M; Nádasy GL; Turu G; Soltész-Katona E; Benyó Z; Offermanns S; Ruisanchez É; Szabó E; Takáts Z; Bátkai S; Tóth ZE; Hunyady L
Mol Cell Endocrinol; 2015 Mar; 403():46-56. PubMed ID: 25595485
[TBL] [Abstract][Full Text] [Related]
9. Alterations of the endocannabinoid system and its therapeutic potential in autism spectrum disorder.
Zou M; Liu Y; Xie S; Wang L; Li D; Li L; Wang F; Zhang Y; Xia W; Sun C; Wu L
Open Biol; 2021 Feb; 11(2):200306. PubMed ID: 33529552
[TBL] [Abstract][Full Text] [Related]
10. Monoacylglycerol Lipase Inhibition Prevents Short-Term Mitochondrial Dysfunction and Oxidative Damage in Rat Brain Synaptosomal/Mitochondrial Fractions and Cortical Slices: Role of Cannabinoid Receptors.
Paredes-Ruiz KJ; Chavira-Ramos K; Galvan-Arzate S; Rangel-López E; Karasu Ç; Túnez I; Skalny AV; Ke T; Aschner M; Orozco-Morales M; Colín-González AL; Santamaría A
Neurotox Res; 2023 Dec; 41(6):514-525. PubMed ID: 37458923
[TBL] [Abstract][Full Text] [Related]
11. Spinal administration of the monoacylglycerol lipase inhibitor JZL184 produces robust inhibitory effects on nociceptive processing and the development of central sensitization in the rat.
Woodhams SG; Wong A; Barrett DA; Bennett AJ; Chapman V; Alexander SP
Br J Pharmacol; 2012 Dec; 167(8):1609-19. PubMed ID: 22924700
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of endocannabinoid signaling with JZL184, an inhibitor of the 2-arachidonoylglycerol hydrolyzing enzyme monoacylglycerol lipase, produces anxiolytic effects under conditions of high environmental aversiveness in rats.
Sciolino NR; Zhou W; Hohmann AG
Pharmacol Res; 2011 Sep; 64(3):226-34. PubMed ID: 21600985
[TBL] [Abstract][Full Text] [Related]
13. Monoacylglycerol lipase controls endocannabinoid and eicosanoid signaling and hepatic injury in mice.
Cao Z; Mulvihill MM; Mukhopadhyay P; Xu H; Erdélyi K; Hao E; Holovac E; Haskó G; Cravatt BF; Nomura DK; Pacher P
Gastroenterology; 2013 Apr; 144(4):808-817.e15. PubMed ID: 23295443
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of monoacylglycerol lipase mediates a cannabinoid 1-receptor dependent delay of kindling progression in mice.
von Rüden EL; Bogdanovic RM; Wotjak CT; Potschka H
Neurobiol Dis; 2015 May; 77():238-45. PubMed ID: 25796567
[TBL] [Abstract][Full Text] [Related]
15. Endocannabinoid signaling in hypothalamic-pituitary-adrenocortical axis recovery following stress: effects of indirect agonists and comparison of male and female mice.
Roberts CJ; Stuhr KL; Hutz MJ; Raff H; Hillard CJ
Pharmacol Biochem Behav; 2014 Feb; 117():17-24. PubMed ID: 24316201
[TBL] [Abstract][Full Text] [Related]
16. Monoacylglycerol lipase inhibitor JZL184 prevents HIV-1 gp120-induced synapse loss by altering endocannabinoid signaling.
Zhang X; Thayer SA
Neuropharmacology; 2018 Jan; 128():269-281. PubMed ID: 29061509
[TBL] [Abstract][Full Text] [Related]
17. Autistic disorder in patients with Williams-Beuren syndrome: a reconsideration of the Williams-Beuren syndrome phenotype.
Tordjman S; Anderson GM; Botbol M; Toutain A; Sarda P; Carlier M; Saugier-Veber P; Baumann C; Cohen D; Lagneaux C; Tabet AC; Verloes A
PLoS One; 2012; 7(3):e30778. PubMed ID: 22412832
[TBL] [Abstract][Full Text] [Related]
18. Monoacylglycerol lipase inhibitor JZL184 is neuroprotective and alters glial cell phenotype in the chronic MPTP mouse model.
Fernández-Suárez D; Celorrio M; Riezu-Boj JI; Ugarte A; Pacheco R; González H; Oyarzabal J; Hillard CJ; Franco R; Aymerich MS
Neurobiol Aging; 2014 Nov; 35(11):2603-2616. PubMed ID: 24973119
[TBL] [Abstract][Full Text] [Related]
19. The monoacylglycerol lipase inhibitor JZL184 attenuates LPS-induced increases in cytokine expression in the rat frontal cortex and plasma: differential mechanisms of action.
Kerr DM; Harhen B; Okine BN; Egan LJ; Finn DP; Roche M
Br J Pharmacol; 2013 Jun; 169(4):808-19. PubMed ID: 23043675
[TBL] [Abstract][Full Text] [Related]
20. Combined inhibition of monoacylglycerol lipase and cyclooxygenases synergistically reduces neuropathic pain in mice.
Crowe MS; Leishman E; Banks ML; Gujjar R; Mahadevan A; Bradshaw HB; Kinsey SG
Br J Pharmacol; 2015 Apr; 172(7):1700-12. PubMed ID: 25393148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
